Stock data
立康 (6242)
立康 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$41.91M, up 7.6% from a year earlier. EPS over the last four quarters totals NT$2.41.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2003-04-23
- Founded
- 1985-04-16
- Paid-in capital
- NT$318.06M
- Common shares issued
- 31,806,500
- Legal name
- 立康生醫事業股份有限公司
- Website
- http://likangbio.com
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$41.91M | +13.2% | +7.6% |
| 2026-08 | NT$37.02M | -12.0% | -0.5% |
Year to date: -3.1% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.78 |
| 2026 Q1 | 0.33 |
| 2025 Q4 | 0.88 |
| 2025 Q3 | 0.42 |
| 2025 Q2 | 0.81 |
| 2025 Q1 | 0.53 |
| 2024 Q4 | 0.82 |
| 2024 Q3 | 0.54 |
Last four quarters: NT$2.41
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 2.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 1,410 | 0.6% |
| 1,000–5,000 shares | 1,290 | 8.1% |
| 5,001–10,000 shares | 207 | 4.8% |
| 10,001–15,000 shares | 64 | 2.6% |
| 15,001–20,000 shares | 22 | 1.2% |
| 20,001–30,000 shares | 38 | 3.0% |
| 30,001–40,000 shares | 11 | 1.2% |
| 40,001–50,000 shares | 8 | 1.1% |
| 50,001–100,000 shares | 15 | 3.2% |
| 100,001–200,000 shares | 12 | 5.1% |
| 200,001–400,000 shares | 6 | 5.1% |
| 400,001–600,000 shares | 2 | 3.5% |
| 600,001–800,000 shares | 1 | 2.1% |
| 800,001–1,000,000 shares | 1 | 2.7% |
| 1,000,001+ shares | 3 | 55.5% |
TDCC data for 2026-10-16: 3 holders own more than 1,000 lots (55.5% of shares), and 1,410 hold less than one lot (0.6%).
Institutional net buying (last 20 trading days)
Data as of 2026-09-10
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-09-10 | 1 | 0 | 0 | 1 |
| 2026-09-07 | 1 | 0 | 0 | 1 |
| 2026-09-03 | 1 | 0 | 0 | 1 |
| 2026-09-02 | 1 | 0 | 0 | 1 |
| 2026-08-14 | -1 | 0 | 0 | -1 |
| 2026-08-12 | 3 | 0 | 0 | 3 |
| 2026-08-10 | 1 | 0 | 0 | 1 |
| 2026-07-31 | 1 | 0 | 0 | 1 |
| 2026-07-21 | -1 | 0 | 0 | -1 |
| 2026-07-15 | 1 | 0 | 0 | 1 |
| 2026-07-14 | -1 | 0 | 0 | -1 |
| 2026-07-13 | -2 | 0 | 0 | -2 |
| 2026-07-08 | -1 | 0 | 0 | -1 |
| 2026-07-07 | -1 | 0 | 0 | -1 |
| 2026-07-01 | -1 | 0 | 0 | -1 |
| 2026-06-29 | -1 | 0 | 0 | -1 |
| 2026-06-18 | -1 | 0 | 0 | -1 |
| 2026-06-17 | 1 | 0 | 0 | 1 |
| 2026-06-16 | -1 | 0 | 0 | -1 |
| 2026-06-09 | 1 | 0 | 0 | 1 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 1 lots.
Price (official close)
Data as of 2026-10-16
Last close NT$34.00 (2026-10-16); 52-week range NT$33.60–40.45.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.